Industry Standard Research
Full Report List
Service Provider Quality Benchmarking Reports
Trends & Technology Reports
Clinical Trial Recruitment & Retention Reports
Department Models & Structures Reports
Biosimilars & Biologics Reports
Library Access Subscription
Core Industry Metrics
ISR Health Panel
CORE INDUSTRY METRICS
CRO & CMO Awards
2018 Clinical Development and Manufacturing Year in Review
mHealth in Clinical Trials
The Interconnected World of Blockbuster Pharmaceuticals
CRO Industry Dynamics
Clinical Trials Pipeline Focus
Clinical Trials Operational Changes
CRO Phase I Environment
CRO Phase II/III Environment
CRO Phase IV Environment
The Ideal vs. Non-Ideal Provider
2017 Clinical Development and Manufacturing Year in Review
Six Questions to Ask About Your Market Research
The CenterWatch Monthly: Reality of costs and impact rain on Sunshine Act
The Expanding Web of Clinical Trial Patient Recruitment
What Does the Future Hold for Clinical Monitoring?
The Sunshine Act and Clinical Research: Views from Principal Investigators and Primary Care Physicians
Perfect Partners: The Key to a Fruitful and Lasting Relationship
MSL and Sales Strategies for the US Oncology Market
CRO Service Quality and Corporate Performance
Recalculating CRO Strategies
CRO Differentiation Whitepaper
Patient and Investigator Recruitment White Paper
Biotech Pulse Survey
April ’19: Are Outsourcers Interested In Changing Their CRO Mix?
March ’19: What goes into a CRA Salary?
February ’19: mHealth in Clinical Trials—Why and How?
January ’19: Clinical Research M&A—A Slower Year
December ’18: A Look at 2018’s CDMO Expansions
November ’18: The Interconnected World of Blockbuster Oncology Drugs
October ’18: The Top 5 Selection Drivers for Phase IV Services
September ’18: Department Influence On CMO Selection
August ’18: Choosing a development stage eCOA/ePRO provider
July ’18: What are the largest slices of the CRO Market?
June ’18: Is the U.S. Biosimilar Industry Falling Behind?
May ’18: Trial Data Collection—Paper vs. Electronic